Medicare Enrolled
Dr. Robert Tokarek, MD
Dermatology · Warminster, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tokarek from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tokarek?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tokarek
Dr. Robert Tokarek is a dermatology specialist in Warminster, PA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Tokarek performed 7,060 Medicare services across 4,498 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tokarek received a total of $189,703 from 43 pharmaceutical and/or device companies across 1283 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tokarek is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 9% volume in PA
$189,703 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,060
Medicare services
Top 9% in PA for dermatology
4,498
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~336 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
2,041 | $5 | $25 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,984 | $62 | $167 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
745 | $43 | $126 |
| Ultraviolet light skin treatment Application of ultraviolet light to the skin for therapeutic purposes. |
315 | $20 | $46 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
277 | $83 | $214 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
254 | $77 | $208 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
233 | $73 | $192 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
221 | $1 | $2 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
153 | $38 | $105 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
110 | $85 | $235 |
| Shaving of skin growth, 0.6-1.0 cm A minor procedure to shave off a skin growth on the body, arms, or legs that measures between 0.6 and 1.0 centimeters. |
79 | $87 | $230 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
70 | $133 | $336 |
| Shaving of skin growth, 1.1-2.0 cm This procedure involves shaving off a skin growth measuring between 1.1 and 2.0 centimeters from the body, arms, or legs. |
69 | $96 | $259 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
44 | $43 | $95 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
42 | $37 | $107 |
| Shaving of skin growth on face, 0.6-1.0 cm This procedure involves shaving off a skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the growth being removed is between 0.6 and 1.0 centimeters. |
41 | $87 | $258 |
| Skin growth shaving, 0.5 cm or less This procedure involves shaving off a small skin growth measuring 0.5 centimeters or less from the body, arms, or legs. |
39 | $64 | $192 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
38 | $135 | $318 |
| Destruction of cancer skin growth, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that measures between 0.6 and 1.0 centimeters. |
35 | $97 | $278 |
| Shaving of small skin growth on face or mouth area A minor procedure to shave off a small skin growth, measuring 0.5 cm or less, located on the face, ears, eyelids, nose, lips, or mouth. |
32 | $89 | $221 |
| Shaving of skin growth, 1.1-2.0 cm Removal of a skin growth by shaving the surface of the skin. The procedure is performed on the face, ears, eyelids, nose, lips, or mouth and involves a lesion measuring between 1.1 and 2.0 centimeters. |
28 | $123 | $296 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
28 | $44 | $134 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
27 | $9 | $50 |
| Shaving of skin growth, 0.6-1.0 cm A minor procedure to shave off a skin growth measuring 0.6 to 1.0 cm from the scalp, neck, hands, feet, or genitals. |
22 | $71 | $232 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
21 | $64 | $182 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
20 | $105 | $238 |
| Destruction of cancerous skin growth on face, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 0.6 and 1.0 centimeters in diameter. |
20 | $150 | $339 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
20 | $121 | $308 |
| Shaving of skin growth, 1.1-2.0 cm Removal of a skin growth by shaving the surface. The procedure is performed on the scalp, neck, hands, feet, or genitals and involves a lesion measuring between 1.1 and 2.0 centimeters. |
19 | $107 | $263 |
| Shaving of skin growth, more than 2.0 cm Removal of a skin growth by shaving the surface with a blade. This procedure is performed on the body, arms, or legs when the growth exceeds 2.0 centimeters. |
17 | $112 | $287 |
| Destruction of cancer skin growth, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin growth measuring 0.6 to 1.0 centimeters. It is performed on the scalp, neck, hands, feet, or genitals. |
16 | $130 | $314 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$189,703
Total received (2018-2024)
Avg $27,100/year across 7 years
Top 3% in PA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
1,283
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$166,584 (87.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,196 (8.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,923 (4.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$15,292
2023
$20,922
2022
$29,921
2021
$11,946
2020
$17,551
2019
$50,661
2018
$43,410
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$11,989
ABBVIE INC.
$655
Lilly USA, LLC
$333
Novartis Pharmaceuticals Corporation
$324
SUN PHARMACEUTICAL INDUSTRIES INC.
$278
UCB, Inc.
$264
E.R. Squibb & Sons, L.L.C.
$239
GENZYME CORPORATION
$222
PFIZER INC.
$203
Dermavant Sciences, Inc.
$191
Arcutis Biotherapeutics, Inc.
$179
LEO Pharma Inc.
$141
Regeneron Healthcare Solutions, Inc.
$103
Galderma Laboratories, L.P.
$101
Amgen Inc.
$42
Incyte Corporation
$29
Top 3 companies account for 84.9% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Scientific Affairs, LLC
$104,641
Janssen Biotech, Inc.
$35,761
Galderma Laboratories, L.P.
$21,627
Novartis Pharmaceuticals Corporation
$8,568
Amgen Inc.
$8,039
Regeneron Healthcare Solutions, Inc.
$955
AbbVie Inc.
$952
ABBVIE INC.
$932
Lilly USA, LLC
$926
GENZYME CORPORATION
$839
UCB, Inc.
$832
Sun Pharmaceutical Industries Inc.
$558
E.R. Squibb & Sons, L.L.C.
$531
Incyte Corporation
$530
SUN PHARMACEUTICAL INDUSTRIES INC.
$454
LEO Pharma Inc.
$435
AbbVie, Inc.
$401
PFIZER INC.
$329
Arcutis Biotherapeutics, Inc.
$311
EPI Health, LLC
$306
Ortho Dermatologics, a division of Bausch Health US, LLC
$281
Dermavant Sciences, Inc.
$271
Mission Pharmacal Company
$141
Genentech USA, Inc.
$127
DERMIRA, INC.
$98
Boehringer Ingelheim Pharmaceuticals, Inc.
$90
DUSA Pharmaceuticals, Inc.
$86
Encore Dermatology Inc.
$82
VYNE Pharmaceuticals Inc.
$79
Mayne Pharma Inc.
$69
Celgene Corporation
$60
Helsinn Therapeutics (U.S.), Inc.
$57
Almirall LLC
$52
Taro Pharmaceuticals USA, Inc.
$45
Journey Medical Corporation
$45
Mylan Pharmaceuticals Inc.
$38
Bayer HealthCare Pharmaceuticals Inc.
$37
Merck Sharp & Dohme Corporation
$29
Aclaris Therapeutics, Inc.
$23
Glenmark Therapeutics Inc.
$22
Kyowa Kirin, Inc.
$18
PruGen, Inc. Pharmaceuticals
$15
STRATA Skin Sciences, Inc.
$12
Top 3 companies account for 85.4% of all-time payments
Associated products mentioned in payments ›
20% · ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMZEEQ · ARAZLO · Absorica LD · Avar · BIAFINE · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · Bensal HP · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cimzia · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dermatological Psoriasis and Vitiligo Treatment · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Enbrel · Erivedge · Finacea · HALOG (Halcinonide Cream · HALOG OINTMENT (Halcinonide Ointment · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · JUBLIA · JUBLIA EFINACONAZOLE · LEVULAN KERASTICK · LIBTAYO · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · Mupirocin Cream · ODOMZO · OLUMIANT · ONEXTON · OPZELURA · ORACEA · Olux · Olux-E · Otezla · POTELIGEO · QBREXZA · REMICADE · RETIN-A-MICRO · RHOFADE · RINVOQ · SILIQ · SIVEXTRO · SKYRIZI · SOOLANTRA · SPEVIGO · STELARA · Seysara · Sitavig · Skyrizi · Sotyktu · TALTZ · TREMFYA · TRI-LUMA · TWYNEO · TargaDox · Tremfya · USP) 0.1% · VALCHLOR · VTAMA · Veltin · Winlevi · XELJANZ · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (88%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in dermatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for dermatology in PA.
Geographic Context
Dermatologists within 10 mi
315
Per 100K population
48.8
County median income
$111,951
Nearest hospital
JEFFERSON ABINGTON HOSPITAL
6.9 mi
6.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Tokarek is a clinical cardiology specialist, with above-average Medicare volume (top 9% in PA), with speaking/promotional industry engagement in the top 3% of PA peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Tokarek experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Tokarek performed 2,041 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tokarek receive payments from pharmaceutical companies?
Yes. Dr. Tokarek received a total of $189,703 from 43 companies across 1,283 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tokarek's costs compare to other dermatologists in Warminster?
Dr. Tokarek's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tokarek) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Warminster
Browse dermatologists in Warminster ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in PA
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in PA
Which PA dermatologists receive the most from drug and device companies.
By company
Janssen Scientific Affairs, LLC Payments to Doctors
See all physicians who received payments from Janssen Scientific Affairs, LLC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Galderma Laboratories, L.P. Payments to Doctors
See all physicians who received payments from Galderma Laboratories, L.P.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology